.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Medtronic
Dow
Queensland Health
US Army
Accenture
UBS
McKinsey
Daiichi Sankyo
Merck

Generated: December 17, 2017

DrugPatentWatch Database Preview

Prednisolone sodium phosphate; sulfacetamide sodium - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for prednisolone sodium phosphate; sulfacetamide sodium and what is the scope of prednisolone sodium phosphate; sulfacetamide sodium freedom to operate?

Prednisolone sodium phosphate; sulfacetamide sodium
is the generic ingredient in three branded drugs marketed by Bausch And Lomb, Sandoz Inc, Akorn, and Novartis, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.

There are eighty-six drug master file entries for prednisolone sodium phosphate; sulfacetamide sodium. Four suppliers are listed for this compound.

Summary for prednisolone sodium phosphate; sulfacetamide sodium

Pharmacology for prednisolone sodium phosphate; sulfacetamide sodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz IncSULFACETAMIDE SODIUM AND PREDNISOLONE SODIUM PHOSPHATEprednisolone sodium phosphate; sulfacetamide sodiumSOLUTION/DROPS;OPHTHALMIC073630-001May 27, 1993ATRXNoNo► Subscribe► Subscribe► Subscribe
NovartisVASOCIDINprednisolone sodium phosphate; sulfacetamide sodiumSOLUTION/DROPS;OPHTHALMIC018988-001Aug 26, 1988DISCNYesNo► Subscribe► Subscribe► Subscribe
Bausch And LombSULFACETAMIDE SODIUM AND PREDNISOLONE SODIUM PHOSPHATEprednisolone sodium phosphate; sulfacetamide sodiumSOLUTION/DROPS;OPHTHALMIC074449-001Dec 29, 1995ATRXNoYes► Subscribe► Subscribe► Subscribe
AkornSULSTERprednisolone sodium phosphate; sulfacetamide sodiumSOLUTION/DROPS;OPHTHALMIC074511-001Jul 30, 1996DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cipla
Julphar
Mallinckrodt
McKesson
Express Scripts
McKinsey
AstraZeneca
Dow
US Army
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot